CLINICAL_TRIALS
research
· 2016-08-15
Clinical Trial Update: A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) [Phase 3]
Summary
A Phase 3 prospective trial in chronic hepatitis B patients who have prior exposure to nucleos(t)ide analogs (the anchor study) is sponsored by Tongji Hospital;…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tongji Hospital | Conditions: Hepatitis B, Chronic | Phase 3 | Status: UNKNOWN